• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性乳腺癌中微小RNA机制组件调控的复杂性

Complexity in regulation of microRNA machinery components in invasive breast carcinoma.

作者信息

Kwon Sun Young, Lee Jae-ho, Kim Bora, Park Jong-Wook, Kwon Taeg Kyu, Kang Sun Hee, Kim Shin

机构信息

Department of Pathology, School of Medicine, Keimyung University, 1095 Dalgubeoldaero, Dalseo-Gu, Daegu, 704-701, South Korea.

出版信息

Pathol Oncol Res. 2014 Jul;20(3):697-705. doi: 10.1007/s12253-014-9750-5. Epub 2014 Feb 27.

DOI:10.1007/s12253-014-9750-5
PMID:24574065
Abstract

Altered expression of microRNA (miRNA) machinery components may play an important role in breast cancer progression. The objective of the current study was to evaluate Drosha, the DiGeorge syndrome critical region gene 8 (DGCR8), Dicer, and Argonaute 2 (AGO2) mRNA expression in invasive breast carcinoma (IBC) and to assess the value of clinical parameters on their expression. By using quantitative real-time PCR, we examined the expression of the four miRNA machinery components in 52 breast tumor tissues which are diagnosed as invasive ductal carcinoma and adjacent non-neoplastic tissues. In the present study, decreased mRNA expression levels of major miRNA machinery components were observed in IBC. The altered mRNA expression levels of DGCR8 and AGO2 are positively correlated with to each other. This study revealed for the first time that expression alterations of DGCR8 are significantly associated with estrogen receptor and Ki-67 status in IBC. Moreover, AGO2 mRNA expression level was significantly correlated with N stage. These results provided evidences that down-regulated the four miRNA machinery components may play an important role in breast pathobiology and that DGCR8 and AGO2 might be associated with important clinical factors.

摘要

微小RNA(miRNA)机制成分的表达改变可能在乳腺癌进展中起重要作用。本研究的目的是评估Drosha、迪格奥尔格综合征关键区域基因8(DGCR8)、Dicer和Argonaute 2(AGO2)在浸润性乳腺癌(IBC)中的mRNA表达,并评估临床参数对其表达的价值。通过定量实时PCR,我们检测了52例被诊断为浸润性导管癌的乳腺肿瘤组织及相邻非肿瘤组织中四种miRNA机制成分的表达。在本研究中,IBC中主要miRNA机制成分的mRNA表达水平降低。DGCR8和AGO2的mRNA表达水平改变彼此呈正相关。本研究首次揭示,DGCR8的表达改变与IBC中的雌激素受体和Ki-67状态显著相关。此外,AGO2 mRNA表达水平与N分期显著相关。这些结果提供了证据,表明四种miRNA机制成分的下调可能在乳腺病理生物学中起重要作用,并且DGCR8和AGO2可能与重要临床因素相关。

相似文献

1
Complexity in regulation of microRNA machinery components in invasive breast carcinoma.浸润性乳腺癌中微小RNA机制组件调控的复杂性
Pathol Oncol Res. 2014 Jul;20(3):697-705. doi: 10.1007/s12253-014-9750-5. Epub 2014 Feb 27.
2
Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.微小RNA调控因子Drosha、Dicer和Ago2在非小细胞肺癌中的表达
Cell Oncol (Dordr). 2015 Aug;38(4):307-17. doi: 10.1007/s13402-015-0231-y. Epub 2015 Jul 31.
3
Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.Argonaute、Dicer 和 Drosha 在浆液性卵巢癌的肿瘤进展过程中上调。
Hum Pathol. 2012 Nov;43(11):2062-9. doi: 10.1016/j.humpath.2012.02.016. Epub 2012 May 29.
4
Dysregulated expression of dicer and drosha in breast cancer.乳腺癌中 dicer 和 drosha 的表达失调。
Pathol Oncol Res. 2012 Apr;18(2):343-8. doi: 10.1007/s12253-011-9450-3. Epub 2011 Sep 7.
5
Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.Dicer和Ago2的下调与前列腺癌中的细胞增殖和凋亡相关。
Tumour Biol. 2014 Nov;35(11):11571-8. doi: 10.1007/s13277-014-2462-3. Epub 2014 Aug 19.
6
Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells.乳腺癌细胞中 microRNA(miRNA)靶标的综合分析。
J Biol Chem. 2013 Sep 20;288(38):27480-27493. doi: 10.1074/jbc.M113.491803. Epub 2013 Aug 6.
7
Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.自噬降解 SQSTM1 通过降低 DICER1 和 AGO2 诱导 MIRLET7A-3P,从而抑制卵巢癌细胞的迁移。
Autophagy. 2018;14(12):2065-2082. doi: 10.1080/15548627.2018.1501135. Epub 2018 Aug 17.
8
Transcript Level of MicroRNA Processing Elements in Gastric Cancer.胃癌中微小RNA加工元件的转录本水平
J Gastrointest Cancer. 2019 Dec;50(4):855-859. doi: 10.1007/s12029-018-0154-8.
9
Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation.敲除调控 microRNA 生物发生的核心蛋白对肺癌细胞对电离辐射的敏感性没有影响。
PLoS One. 2012;7(3):e33134. doi: 10.1371/journal.pone.0033134. Epub 2012 Mar 30.
10
Dicer, Drosha, and outcomes in patients with ovarian cancer.Dicer、Drosha与卵巢癌患者的预后
N Engl J Med. 2008 Dec 18;359(25):2641-50. doi: 10.1056/NEJMoa0803785.

引用本文的文献

1
p63, a key regulator of Ago2, links to the microRNA-144 cluster.p63是Ago2的关键调节因子,与微小RNA-144簇相关联。
Cell Death Dis. 2022 Apr 22;13(4):397. doi: 10.1038/s41419-022-04854-1.
2
Analysis of The Cancer Genome Atlas data to determine the correlation between AGO2, TERT, and TERC in various cancers.分析癌症基因组图谱数据,以确定AGO2、端粒酶逆转录酶(TERT)和端粒酶RNA组分(TERC)在各种癌症中的相关性。
Transl Cancer Res. 2019 Oct;8(6):2504-2505. doi: 10.21037/tcr.2019.09.41.
3
Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma.

本文引用的文献

1
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学会临床实践指南更新。
J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.
2
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients.乳腺癌患者内乳前哨淋巴结转移识别的影响
Ann Surg Oncol. 2014 Jan;21(1):60-5. doi: 10.1245/s10434-013-3276-z. Epub 2013 Sep 18.
3
转录组数据集中差异表达的微小RNA的综合高通量荟萃分析揭示了成人T细胞白血病/淋巴瘤中MAPK/JNK信号转导通路的显著破坏。
Infect Agent Cancer. 2021 Jun 29;16(1):49. doi: 10.1186/s13027-021-00390-3.
4
The prognostic value of microRNA-biogenesis genes and variants in breast cancer patients.微小RNA生物合成基因及变异体在乳腺癌患者中的预后价值
Am J Transl Res. 2020 May 15;12(5):1994-2006. eCollection 2020.
5
From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies.从阿尔戈英雄神话水手到 Argonautes RNA 沉默导航者:它们在人类细胞病理学中的新兴作用。
Int J Mol Sci. 2020 Jun 3;21(11):4007. doi: 10.3390/ijms21114007.
6
Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells.AGO2 驱动乳腺癌细胞中 miR-145-5p 依赖的基因表达程序。
Cell Death Dis. 2019 Jan 8;10(1):17. doi: 10.1038/s41419-018-1267-5.
7
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading.核受体 ERβ 与 AGO2 结合,调节基因转录、RNA 剪接和 RISC 加载。
Genome Biol. 2017 Oct 6;18(1):189. doi: 10.1186/s13059-017-1321-0.
8
miRNA biogenesis-associated RNase III nucleases Drosha and Dicer are upregulated in colorectal adenocarcinoma.与微小RNA(miRNA)生物合成相关的核糖核酸酶III核酸酶Drosha和Dicer在结肠直肠癌中上调。
Oncol Lett. 2017 Oct;14(4):4379-4383. doi: 10.3892/ol.2017.6674. Epub 2017 Jul 26.
9
Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.亚洲韩国乳头状甲状腺癌中miRNA加工相关基因Dicer、Drosha、DGCR8和AGO2表达水平的种族差异及使用癌症基因组图谱的比较验证
Int J Genomics. 2017;2017:5789769. doi: 10.1155/2017/5789769. Epub 2017 Mar 2.
10
Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells.CHO-K1细胞中miR-29b-1/a转录的调控及靶mRNA的鉴定
Mol Cell Endocrinol. 2017 Mar 15;444:38-47. doi: 10.1016/j.mce.2017.01.044. Epub 2017 Jan 28.
The clinical significance of Ki-67 as a marker of prognostic value and chemosensitivity prediction in hormone-receptor-positive breast cancer: a meta-analysis of the published literature.
Ki-67 作为激素受体阳性乳腺癌预后价值和化疗敏感性预测标志物的临床意义:已发表文献的荟萃分析。
Curr Med Res Opin. 2013 Nov;29(11):1453-61. doi: 10.1185/03007995.2013.833088. Epub 2013 Sep 11.
4
An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas.一种对微小RNA成熟至关重要的微处理器复合体成分DGCR8在结直肠癌中上调。
Clin Exp Med. 2014 Aug;14(3):331-6. doi: 10.1007/s10238-013-0243-8. Epub 2013 Jun 18.
5
Ki67 and proliferation in breast cancer.Ki67 与乳腺癌增殖。
J Clin Pathol. 2013 Jun;66(6):512-6. doi: 10.1136/jclinpath-2012-201085. Epub 2013 Feb 22.
6
MicroRNAs as potential biomarkers in human solid tumors.微小 RNA 作为人类实体肿瘤的潜在生物标志物。
Cancer Lett. 2013 Feb 28;329(2):125-36. doi: 10.1016/j.canlet.2012.11.001. Epub 2012 Nov 27.
7
Loss of Dicer expression is associated with breast cancer progression and recurrence.Dicer 表达缺失与乳腺癌的进展和复发相关。
Breast Cancer Res Treat. 2012 Sep;135(2):403-13. doi: 10.1007/s10549-012-2169-3. Epub 2012 Jul 21.
8
Expression of Dicer and Drosha in triple-negative breast cancer.Dicer 和 Drosha 在三阴性乳腺癌中的表达。
J Clin Pathol. 2012 Apr;65(4):320-6. doi: 10.1136/jclinpath-2011-200496. Epub 2012 Jan 18.
9
Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer.上皮性皮肤癌中 microRNA 成熟微处理器复合物成分 DGCR8 和 RNA 诱导沉默复合物 (RISC) 成分 Argonaute-1、Argonaute-2、PACT、TARBP1 和 TARBP2 的表达水平。
Mol Carcinog. 2012 Nov;51(11):916-22. doi: 10.1002/mc.20861. Epub 2011 Oct 24.
10
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.乳腺癌中 Ki67 的评估:国际乳腺癌 Ki67 工作组的建议。
J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64. doi: 10.1093/jnci/djr393. Epub 2011 Sep 29.